SOAT1 and lung carcinoma: It was well known that abnormal activation of the JAK-STAT pathway strongly made attribution to the occurrence, development, drug resistance and poor prognosis of various tumors, including lung cancer, colorectal cancer, breast cancer and PTC [49–52].